China approves two domestically developed Coronavirus drugs for patients with mild symptoms
Image Credit: reuters
China has approved two domestically developed COVID-19 drugs, according to a report in Reuters. The news was confirmed by the National Medical Products Administration which said that the drugs have been developed as oral medicines for COVID-19 patients with mild symptoms. The drugs have been developed by Simcere Pharmaceutical Group and a unit of Shanghai Junshi Biosciences Co Ltd.